Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma
Publication

Publications

The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma

Title
The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma
Type
Article in International Scientific Journal
Year
2014
Authors
Ana S Soares
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Vera M Costa
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Carmen Diniz
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
Vol. 74
Pages: 847-860
ISSN: 0344-5704
Publisher: Springer Nature
Scientific classification
FOS: Medical and Health sciences > Clinical medicine
Other information
Authenticus ID: P-009-VY7
Abstract (EN): Metastatic melanoma is considered one of the most aggressive malignant tumours, representing the deadliest form of skin cancer. Melanoma progression is associated with the abrogation of normal controls that limit cell proliferation, migration, and invasion, eventually leading to metastasis. Based on the variety of cellular mechanisms involved in metastatic progression, we aimed to evaluate the effect of inosine (50 mu M) and of the combination of Cl-IB-MECA (10 mu M) with paclitaxel (10 ng/mL) on several stages of melanoma progression. Proliferation, migration, adhesion, invasion, and colony formation assays were performed on human C32 and A375 metastatic melanoma cells. Levels of ERK1/2 were also determined using an ELISA kit. Moreover, mouse aortic rings were treated with vascular endothelial growth factor in order to assess the microvessel sprouting (an indicator of angiogenesis) in the presence of the referred compounds. We demonstrate that inosine induced, through A(3) adenosine receptor activation, proliferation, migration, adhesion, and invasion on C32 and A375 melanoma cells, although with dissimilar importance on the two melanoma cell lines. Inosine also increased colony formation on A375 cells. Levels of ERK1/2 were increased after inosine exposure and that increase was dependent on A(3) adenosine receptor activation in both cell lines. Moreover, microvessel sprouting stimulated by inosine was decreased by the combination of Cl-IB-MECA with paclitaxel. Cl-IB-MECA combined with paclitaxel was able to impair almost all of the referred metastatic related mechanisms induced by inosine, making this approach a valuable tool for combinatory therapy against metastatic melanoma.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 14
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Uveal melanoma: physiopathology and new in situ-specific therapies (2019)
Another Publication in an International Scientific Journal
Souto, EB; Zielinska, A; Luis, M; Carbone, C; Martins Gomes, C; Souto, SB; Silva, AM
The role of the glutamine transporter ASCT2 in antineoplastic therapy (2021)
Article in International Scientific Journal
Teixeira, E; Silva, C; Martel, F
Liposomal therapies in oncology: does one size fit all? (2018)
Article in International Scientific Journal
Sousa, I; Rodrigues, F; Prazeres, H; Lima, RT; Soares, P
Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy (2010)
Article in International Scientific Journal
Augusto Nogueira; Raquel Catarino; Ana Coelho; Antonio Araujo; Monica Gomes; Rui Medeiros
Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma (2024)
Article in International Scientific Journal
Sousa, SM; Branco, H; Avan, A; Palmeira, A; Morelli, L; Santos, LL; Giovannetti, E; Helena Vasconcelos, MH; Xavier, CPR
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-12 at 21:52:06 | Privacy Policy | Personal Data Protection Policy | Whistleblowing